Exploration of Blood Flow Regulation to Bone in Humans
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04083794 |
Recruitment Status :
Recruiting
First Posted : September 10, 2019
Last Update Posted : February 22, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Bone Blood Flow Regulation | Other: Laboratory based assessments | Not Applicable |
All tissues of the human body require adequate perfusion to provide oxygen and nutrients to meet metabolic demands. It has long been known that the arterial system in bone is of overwhelming importance and that without blood flow, bone cannot maintain its integrity. Indeed, there is an extensive network of arteries, arterioles, and capillaries that supply human bone. Moreover, blood flow to bone is responsive to various local and systemic factors that can determine the overall health of bone. However, bone perfusion in humans remains relatively unstudied and so the underlying mechanisms that regulate bone blood flow are not well understood. The investigators propose to study key mechanisms that regulate bone perfusion in able-bodied individuals and to contrast them with spinal cord injured (SCI) individuals. SCI represents a human 'model' of chronic reduced loading with loss of sympathetic regulation below the level of injury that likely alters control of bone perfusion. Accordingly, our aims are to: 1) Determine the impact of compressive loading with and without associated muscle contractions on tibial perfusion; 2) Determine the impact of vascular sympathetic activity and systemic perfusion pressure on tibial perfusion; 3) Compare the changes in tibial perfusion in response to local and systemic factors between able-bodied and those with SCI.
The majority of work in bone blood flow has been in animals and/or has focused on the association between adequate or inadequate perfusion and bone health. For example, inadequate flow has been associated with bone loss, impaired growth, and delayed fracture healing. However, the acute metabolic needs of bone due to loading either with or without associated muscle contractions increase flow substantially. Indeed, within two minutes of isolated muscle contractions alone, tibial perfusion has been shown to increase significantly. Furthermore, when there is compressive loading with associated muscle contractions, flow to bone can double. Similarly, skeletal unloading for as short as ten minutes cuts femoral perfusion by half. Although it is unclear what specific local factors (e.g., metabolic by-products) with loading might be responsible for regulation of blood flow, these data strongly suggest that perfusion to bone is highly responsive to skeletal loading. Indeed, it appears that similar regulatory mechanisms may be at play in control of flow to bone and skeletal muscle during exercise. In addition, the bone vasculature is richly innervated by sympathetic nerves. Application of norepinephrine decreases blood flow to both intact bone and isolated bone. Likewise, sympathetic stimulation decreases flow to bone via alpha-adrenergic receptor activation. Moreover, smooth muscle of arterioles in bone respond as expected to vasodilators and vasoconstrictors. Hence, sympathetic innervation of the bone vasculature serves a functional purpose in control of flow. If this were not the case, independent of the link between bone metabolism and bone flow, the arterial network in bone would act as a simple pressure passive system.
A critical limitation to the study of bone flow in humans has been the lack of noninvasive assessments. Thus, it has been difficult to elucidate the mechanisms that control perfusion to bone. The dense nature of bone makes it difficult to investigate perfusion and the techniques used to quantify circulation in other tissues are either difficult or impossible to apply to bone in vivo. the investigators recently demonstrated the efficacy of a near infrared spectroscopy (NIRS) system to non-invasively detect changes in hemoglobin content in the tibia. Although our preliminary work showed the utility of NIRS, it was not designed to provide insight to blood flow regulation and disentangle the various possible contributors to bone perfusion. Here the investigators propose to study different mechanisms that control blood flow to bone in both able-bodied and spinal cord injured (SCI). The SCI population will offer valuable insights to the mechanisms of perfusion as several contributors (i.e. loading and vascular sympathetic control) are either reduced or disrupted.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 130 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | This is a Basic Experimental study with Humans with able-bodied individuals and individuals with spinal cord injury (SCI). This study is a cross sectional assessment and will have 1 or 2 visits consisting of 2 protocols where individuals will undergo several physical maneuvers during which bone perfusion response will be assessed. Protocol #1 will investigate tibial perfusion response to tibial loading. Protocol #2 will investigate tibial perfusion response to isometric handgrip exercise and tilt. Volunteers can choose to do one or both protocols during 1 or 2 laboratory visits. |
Masking: | None (Open Label) |
Primary Purpose: | Basic Science |
Official Title: | Exploration of Blood Flow Regulation to Bone in Humans |
Actual Study Start Date : | November 26, 2019 |
Estimated Primary Completion Date : | June 30, 2023 |
Estimated Study Completion Date : | June 30, 2023 |

Arm | Intervention/treatment |
---|---|
Laboratory based assessments
The current study has no arms; it is a cross-sectional assessment where all participants will undergo the same procedures.
|
Other: Laboratory based assessments
physical maneuvers to assess physiological responses in bone blood flow
Other Names:
|
- Tibial blood perfusion [ Time Frame: 1 day ]Concentration of hemoglobin content assessed in response to several physical maneuvers (tibial loading, isometric handgrip, and tilt)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- healthy males and females
- individuals with spinal cord injuries, between 3 and 24 months post injury, with complete injuries according to the American Spinal Injury Association Impairment Scale A and B, with injuries at T6 and below
Exclusion Criteria:
- clinical signs or symptoms of heart disease
- hypertension
- coronary disease
- diabetes
- other neurological disease
- cancer
- recent weight change >15 pounds
- abnormal resting ECG
- pregnant and/or breastfeeding women
- underweight and obese individuals (body mass index between 18.5 and 29.9)
- use of amphetamines (Ritalin, Adderall, Concerta) in the past 48 hours
- tibial fracture or tibial stress fracture in the past year
- those with SCI will have no extreme spasticity to avoid spontaneous contractions
- use of baclofen for those with SCI

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04083794
Contact: Adina E Draghici, PhD | 6177585508 | adraghici@mgh.harvard.edu | |
Contact: J. A Taylor, PhD | 6177585503 | jandrew_taylor@hms.harvard.edu |
United States, Massachusetts | |
Spaulding Rehabilitation Cambridge/ Cardiovascular Laboratory | Recruiting |
Cambridge, Massachusetts, United States, 02138 | |
Contact: Adina E Draghici, PhD 617-758-5508 adraghici@mgh.harvard.edu | |
Contact: Glen Picard 6177585511 gpicard@partners.org | |
Principal Investigator: J. A Taylor, PhD |
Principal Investigator: | J. A Taylor, PhD | Harvard Medical School/Spaulding Rehabilitation Hospital |
Responsible Party: | J. Andrew Taylor, Associate Chair for Research, Spaulding Rehabilitation Hospital |
ClinicalTrials.gov Identifier: | NCT04083794 |
Other Study ID Numbers: |
2018P000156 R21AR074054-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | September 10, 2019 Key Record Dates |
Last Update Posted: | February 22, 2023 |
Last Verified: | February 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
bone perfusion bone blood flow regulation vascular sympathetic activity skeletal loading spinal cord injury |